DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 1967--------------------------------------------------
       European Commission approves Ocrevus for early PPMS
       By: agate Date: January 27, 2018, 1:46 am
       ---------------------------------------------------------
       The European Commission has approved Ocrevus for use in early
       PPMS. What is meant by "early PPMS" isn't spelled out but there
       is this statement in an article about the approval of Ocrevus by
       the EMA (European Medicines Agency):
       [quote] The EMA is recommending that for PPMS, ocrelizumab
       should only be prescribed for people with early PPMS, according
       to the duration of their MS symptoms, their level of disability
       and whether their MRI results indicate inflammatory activity.
       The EMA notes that more investigation is required before this
       treatment can be recommended for people in more advanced stages
       of disability.[/quote]
       "First treatment in Europe approved for early primary
       progressive MS," from the MS International Federation, January
       24, 2018:
  HTML https://www.msif.org/news/2018/01/12/first-treatment-europe-approved-early-primary-progressive-ms/?lang=en
       *****************************************************